Rose McNulty


FDA Grants Accelerated Approval to Lifileucel, First-Ever Immunotherapy For Unresectable, Metastatic Melanoma

The FDA's decision represents a landmark approval of a tumor-derived cellular therapy in a solid tumor cancer.

Ron King


Drive Value-based Care With Genetic Testing and Precision Medicine

The shift to value-based care in the U.S. has been slow in coming, in large part because providers have continued to cling to the traditional “fee for service” healthcare model that historically has worked well for them.

Demetra Anastasiadis, BPS, PharmD candidate


COVID-19 Vaccines: A Focus on Safety

Ease patients’ concerns by being well versed in the safety profiles of each vaccine.

Erin Thimmesch, JD


National Pharmacy Chain Opioid Settlements Poised to Affect Independent Pharmacies

Stipulations of the settlements include data reporting, annual training, and an independent compliance officer.

Michael McKendall, MS, PharmD


The Effects of “Long COVID” and How Pharmacists Can Help

Often referred to as “long COVID” patients or “long-haulers,” these patients continue to experience symptoms of illness far past the acute phase of this viral disease.

Lois Levine


Increase in STIs Among Adolescents Witnessed During COVID-19 Pandemic

As a result of an increase in adolescent inpatient visits with a sexually transmitted infection (STI) diagnosis in 2020, further work is needed to improve STI care, particularly for this demographic.

Annie Lambert, PharmD, BCSCP


The Impact of COVID-19 on Pharmacy Management and Compliance

Pharmacy leaders have leveraged their experience, their role in interdisciplinary teams, and technology to quickly reinvent approaches to manage long-standing issues exacerbated by the pandemic.

Rachel Eyler, PharmD, BCPS


Misdosing: More Common Than You Think

Unfortunately, even though the need for making proper dose adjustments for kidney function is well-recognized, clinicians face many challenges in doing so.

Chelsie Derman


While Telemedicine Decreased After COVID-19 Peak, Mental Health Video Visits Rose

Compared to only 10% of primary and subspecialty visits, 34.5% of mental health visits took place via video in August 2023.

Donovan Quill, President and CEO, Optime Care


Patient-First Approach Addresses Unique Needs of Patients With Rare Disorders

Now more than ever, 30 million Americans living with a range of 7000 rare or orphan diseases require a high level of therapy adherence support.

Molly C. Gombos, PharmD, MPBA


Overcoming Vaccine Hesitancy With Patients

Pharmacists can work with their patients to address concerns about vaccinations.

Ryan Nolan, PharmD Candidate 2021


Belantamab mafodotin-blmf for Relapsed or Refractory Multiple Myeloma

Belantamab mafodotin-blmf is now indicated for adult patients with relapsed or refractory myeloma who have received at least 4 prior therapies.

headshot for Laura Joszt
Laura Joszt, MA


Dupilumab Approved by FDA to Treat Eosinophilic Esophagitis in Children Under 12

Eosinophilic esophagitis is a chronic, progressive disease thought to be responsible for damaging the esophagus, and it can severely impact a child’s ability to eat.

Nada Annr, BPS, PharmD


Thermometers: A Review

Pharmacists must be familiar with the different thermometers so they can ensure proper use by the consumer.



Bempedoic Acid for Hypercholesterolemia

An expert panel discusses where bempedoic acid currently fits into the treatment of hypercholesterolemia.

Debra Lee, MBA, BA


Practice Update: Treating Patients Hospitalized With COVID-19

Several institutions have published guidance on how to treat patients hospitalized with COVID-19.

Kevin Kunzmann


Cell-Based Flu Vaccine May Be More Cost-Effective, Beneficial Among Children

A new study found that switching from a primary national plan of egg-based vaccines to cell-based vaccines for the flu would significantly reduce the impact of the seasonal virus at a lesser production and distribution cost.

Katherine Saunders, M.D.


Insurance Coverage is Lagging in a Golden Age of Obesity Treatment

Antiobesity medications are considered to be 'vanity drugs' by many private insurers, and the refusal to cover obesity treatment is counterproductive because of obesity's many health consequences.

Kevin W. Chamberlin, PharmD, FASCP


Relyvrio: A New FDA-Approved Treatment for Patients With ALS

Relyvrio is intended to slow the disease progression of amyotrophic lateral sclerosis.

Rami Chammas, PharmD, MPBA


The Effects of COVID-19 on Specialty Prescribing Habits

The remote and virtual way of treating patients is becoming the new norm. Specialty providers have to adapt to provide the most streamlined solutions.

Akunna Ihemaguba, BPS, PharmD


Thermometers: A Review

Pharmacists must be familiar with the different thermometers so they can ensure proper use by the consumer.

Kenny Walter


Electrical Nerve Field Stimulation May Help IBS Symptoms in Pediatric Patients

IBS in pediatric patients has not been studied much, but new data reveals a possible treatment.

© 2024 MJH Life Sciences

All rights reserved.